Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Week In Review: Yantai's MabPlex Raises $59 Million To Expand CDMO Services
Article By:
ChinaBio® Today
Sunday, January 20, 2019 10:38 AM EDT
MabPlex, a biologics CDMO, raised $59 million in a Series A round from SDIC Venture Fund and Shenzhen Venture Capital. MabPlex offers biologics development and manufacturing services, including mAbs, recombinant proteins, ADCs and bispecifics.
Week In Review: Shanghai Henlius To File For Hong Kong IPO At Valuation Of Over $1 Billion
Article By:
ChinaBio® Today
Saturday, October 6, 2018 5:57 PM EDT
Shanghai Fosun Pharma announced it will seek a Hong Kong IPO for Shanghai Henlius Biotech, its monoclonal antibody JV subsidiary The company was established to develop mAb biosimilar drugs, bio-betters and novel mAbs.
Week In Review: Agilent Pays $250 Million To Acquire ACEA And Its Cell Therapy Analyzer
Article By:
ChinaBio® Today
Saturday, September 29, 2018 4:11 PM EDT
ACEA Biosciences, a San Diego company with R&D and manufacturing facilities in Hangzhzou, will be acquired by Agilent for $250 million in cash. ACEA developed the xCELLigence® cell therapy analysis device used by academic and biopharma researchers.